Team | Year | Pos | G | IP | PO | A | E | Fld % | RF | Eff | ZR |
---|---|---|---|---|---|---|---|---|---|---|---|
Cayman - DRAKE
CAY - DRAKE
|
2056 | 2B | 1 | 2.0 | 0 | 1 | 0 | 1.000 | 4.50 | .999 | 0.02 |
Cayman - DRAKE
CAY - DRAKE
|
2056 | 3B | 1 | 0.2 | 0 | 0 | 1 | .000 | 0.00 | .540 | -0.56 |
Cayman - DRAKE
CAY - DRAKE
|
2056 | SS | 1 | 1.0 | 0 | 0 | 0 | .000 | 0.00 | .000 | 0.00 |
Assateague - SNL (R)
ASS - SNL (R)
|
2056 | 1B | 3 | 3.0 | 3 | 0 | 0 | 1.000 | 9.00 | .000 | 0.00 |
Assateague - SNL (R)
ASS - SNL (R)
|
2056 | 2B | 1 | 3.0 | 1 | 1 | 0 | 1.000 | 6.00 | 1.041 | 0.06 |
Cayman - DRAKE
CAY - DRAKE
|
2055 | 1B | 3 | 6.2 | 6 | 0 | 0 | 1.000 | 8.10 | .000 | 0.00 |
Cayman - DRAKE
CAY - DRAKE
|
2055 | 2B | 1 | 2.0 | 1 | 1 | 0 | 1.000 | 9.00 | .991 | 0.02 |
Cayman - DRAKE
CAY - DRAKE
|
2055 | 3B | 10 | 53.0 | 1 | 11 | 2 | .857 | 2.04 | .906 | -0.75 |
Assateague - SNL (R)
ASS - SNL (R)
|
2054 | 1B | 9 | 53.0 | 42 | 4 | 0 | 1.000 | 7.81 | 1.031 | 0.35 |
Assateague - SNL (R)
ASS - SNL (R)
|
2054 | 2B | 56 | 444.0 | 105 | 120 | 6 | .974 | 4.56 | .920 | -5.97 |
Assateague - SNL (R)
ASS - SNL (R)
|
2054 | 3B | 11 | 33.0 | 3 | 7 | 1 | .909 | 2.73 | .716 | -1.97 |
Assateague - SNL (R)
ASS - SNL (R)
|
2054 | SS | 4 | 8.0 | 1 | 1 | 0 | 1.000 | 2.25 | 1.069 | 0.01 |
Assateague - SNL (R)
ASS - SNL (R)
|
2053 | 1B | 44 | 372.2 | 349 | 23 | 3 | .992 | 8.98 | 1.006 | 0.83 |
Assateague - SNL (R)
ASS - SNL (R)
|
2053 | RF | 1 | 1.0 | 1 | 0 | 0 | 1.000 | 9.00 | 1.024 | 0.03 |
Assateague - SNL (R)
ASS - SNL (R)
|
2052 | 3B | 63 | 519.0 | 17 | 132 | 2 | .987 | 2.58 | 1.032 | 2.46 |
Assateague - SNL (R)
ASS - SNL (R)
|
2051 | SS | 2 | 4.0 | 0 | 1 | 0 | 1.000 | 2.25 | 1.105 | 0.02 |
Assateague - SNL (R)
ASS - SNL (R)
|
2051 | RF | 30 | 256.1 | 43 | 0 | 3 | .935 | 1.51 | .962 | -1.46 |
Pfizer - HSAS (HS)
PFZ - HSAS (HS)
|
2051 | 3B | 7 | 46.2 | 2 | 8 | 2 | .833 | 1.93 | .897 | -0.94 |
Pfizer - HSAS (HS)
PFZ - HSAS (HS)
|
2051 | SS | 18 | 58.0 | 8 | 21 | 0 | 1.000 | 4.50 | 1.071 | 0.98 |
Pfizer - HSAS (HS)
PFZ - HSAS (HS)
|
2050 | 3B | 20 | 82.1 | 4 | 16 | 1 | .952 | 2.19 | 1.034 | -0.05 |
Pfizer - HSAS (HS)
PFZ - HSAS (HS)
|
2050 | SS | 1 | 3.0 | 0 | 4 | 0 | 1.000 | 12.00 | 1.101 | 0.20 |
Pfizer - HSAS (HS)
PFZ - HSAS (HS)
|
2049 | 3B | 37 | 315.0 | 14 | 66 | 4 | .952 | 2.29 | 1.059 | 3.81 |
Pfizer - HSAS (HS)
PFZ - HSAS (HS)
|
2049 | SS | 2 | 16.0 | 1 | 3 | 0 | 1.000 | 2.25 | 1.432 | 0.55 |
Total | 1B | 59 | 435.1 | 400 | 27 | 3 | 1.17 | ||||
Total | 2B | 59 | 451.0 | 107 | 123 | 6 | -5.88 | ||||
Total | 3B | 149 | 1049.2 | 41 | 240 | 13 | 2.00 | ||||
Total | SS | 28 | 90.0 | 10 | 30 | 0 | 1.76 | ||||
Total | RF | 31 | 257.1 | 44 | 0 | 3 | -1.43 |